Business description: Hubei Jumpcan Pharmaceutical Co., Ltd.

HUBEI JUMPCAN PHARMACEUTICAL CO., LTD., formerly Hubei Hongcheng General Machinery Co., Ltd., is a China-based company, principally engaged in the research and development, production and distribution of pharmaceuticals. The Company's products include heat-clearing and detoxifying series, digestive system series, pediatric series, breathing series, cardiovascular series and gynecology series. Its pharmaceuticals consist of tablets, mixtures, injections, capsules, granules and sprays, among others. The Company mainly distributes its products within domestic markets.

Number of employees: 5,026

Sales by Activity: Hubei Jumpcan Pharmaceutical Co., Ltd.

Fiscal Period: December 2020 (CNY) 2021 (CNY) 2022 (CNY) 2023 (CNY) 2024 (CNY)

Clearing Heat and Detoxifying

214.04Cr 242.21Cr 287.18Cr 337.96Cr 268.84Cr

Pediatrics

103.79Cr 170.06Cr 242.54Cr 274.09Cr 225.37Cr

Digestive

168.97Cr 180.45Cr 176.79Cr 168.67Cr 115.49Cr

Other

64Cr 78Cr 83Cr 71Cr 80Cr

Breathing

28Cr 48Cr 58Cr 64Cr 65Cr

Cardiovascular Type

7.76Cr 8.31Cr 9.62Cr 8.39Cr 7.66Cr

Gynecology

6.22Cr 5.9Cr 5.37Cr 4.07Cr 3.69Cr

Commercial

22Cr 28Cr 35Cr 36Cr 34Cr
See all business segments

Geographical breakdown of sales: Hubei Jumpcan Pharmaceutical Co., Ltd.

Fiscal Period: December 2020 (CNY) 2021 (CNY) 2022 (CNY) 2023 (CNY) 2024 (CNY)

China

616.5Cr 763.05Cr 899.64Cr 965.45Cr 801.69Cr
See all geographic segments

Executive Committee: Hubei Jumpcan Pharmaceutical Co., Ltd.

Manager TitleAgeSince
Chief Executive Officer 43 20/12/2019
Director of Finance/CFO 58 26/09/2022
Corporate Secretary 40 17/09/2018
Corporate Officer/Principal 60 -
See HUBEI JUMPCAN PHARMACEUTICAL CO., LTD. governance

Composition of the Board of Directors: Hubei Jumpcan Pharmaceutical Co., Ltd.

Director TitleAgeSince
Chairman 69 10/03/2014
Director/Board Member 64 10/03/2014
Director/Board Member 43 10/03/2014
Director/Board Member 56 02/03/2020
Chairman 57 08/05/2023
Director/Board Member 52 02/03/2020
Director/Board Member 40 04/07/2022
Director/Board Member 57 25/10/2022
Director/Board Member 50 08/05/2023
Composition of the Board of Directors

Shareholders: Hubei Jumpcan Pharmaceutical Co., Ltd.

NameEquities%Valuation
61.54 %
56,35,95,818 61.54 % 2 121 M ¥
China Southern Asset Management Co., Ltd.
1.083 %
99,16,154 1.083 % 37 M ¥
Yinhua Fund Management Co., Ltd.
0.3914 %
35,84,217 0.3914 % 13 M ¥
China Asset Management Co., Ltd.
0.2732 %
25,01,998 0.2732 % 9 M ¥
Penghua Fund Management Co., Ltd.
0.1805 %
16,52,893 0.1805 % 6 M ¥
NameEquities%Valuation
7.021 %
2,30,400 7.021 % 867 113 ¥
5.119 %
1,68,000 5.119 % 632 270 ¥
4.479 %
1,47,000 4.479 % 553 236 ¥
4.388 %
1,44,000 4.388 % 541 945 ¥
Wenzheng Shi
3.419 %
1,12,200 3.419 % 422 266 ¥
List of HUBEI JUMPCAN PHARMACEUTICAL CO., LTD. shareholders

Company details: Hubei Jumpcan Pharmaceutical Co., Ltd.

Hubei Jumpcan Pharmaceutical Co., Ltd.

Baota Bay

225441, Taizhou

+86 71 6812 4260

http://www.jumpcan.com
address Hubei Jumpcan Pharmaceutical Co., Ltd.(600566)

Alternative Medicine

Change 5d. change 1-year change 3-years change Capi.($)
-0.90%+0.42%-7.17%-8.50% 347.48Cr
-1.15%-4.19%-16.34%-33.91% 611.72Cr
-0.20%-1.64%-20.79%+14.90% 452.89Cr
-1.11%-4.37%+51.94%+45.71% 438.38Cr
-0.96%-2.01%+11.85%-40.12% 420.79Cr
-1.31%-1.70%+7.42%+31.44% 322.67Cr
0.00%-0.48%+7.91%-22.10% 249.71Cr
-0.33%-0.69%+16.59%+3.17% 199.24Cr
-0.52%-1.60%-0.24%+50.97% 169.24Cr
-0.41%+2.47%+15.95%+62.15% 169.22Cr
Average -0.69%-1.22%+6.71%+10.37% 338.13Cr
Weighted average by Cap. -0.78%-1.68%+4.79%+3.14%
See all sector performances
  1. Stock Market
  2. Equities
  3. 600566 Stock
  4. Company Hubei Jumpcan Pharmaceutical Co., Ltd.